New Guidelines: Doctors to Push Use of Cholesterol Drugs

New heart disease prevention guidelines will have doctors recommending cholesterol drugs to double the Americans than what the current guidelines do. More 

5 Overpriced Stocks to Ditch Now

These stocks are either momentum darlings or supposed bastions of safety, but their valuations aren't justified. More 

3 Doomed Investments to Avoid in 2014

Avoiding bad investments can be as important as picking good ones. Investors should stay clear from these doomed investments in 2014. More 

3 New Buys for November – ADS CLB TM

The government is open again, the Fed will continue easing, and a strong period for the markets is ahead. Here are our 3 new buys to help you profit More 

Veeva Systems’ CEO on Driving High Growth AND Profits

Veeva Systems' IPO was red-hot today, surging up 86%. Here's what the company's CEO had to say about the success of VEEV. More 

New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half

Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results. More 

Cloud Computing, 3D Printing Star in Upcoming IPOs

German 3D printer-maker Voxeljet (VJET) and cloud platform operator Veeva Systems (VEEV) are among four companies slated to pull off IPOs this week. More